Bridgeway Capital Management, LLC Tff Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.62 - $1.1 $21,638 - $38,390	-34,900 Reduced 59.45%	23,800 $16,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $95,888 - $2.41 Million	-20,800 Reduced 26.16%	58,700 $238,000
Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $171,500 - $241,250	25,000 Added 45.87%	79,500 $705,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $392,945 - $571,705	54,500 New	54,500 $421,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.92M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.